GTCM
TDOC icon

Gyon Technologies Capital Management’s Teladoc Health TDOC Stock Holding History

Gyon Technologies Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,500
Closed -$230K – 549
2021
Q4 		$230K Buy
+2,500
New +$299K 0.04% 476

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Gyon Technologies Capital Management's TDOC Position: Q1 2022 in Review

Gyon Technologies Capital Management sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 2,500 shares — an estimated $230K sold.

Gyon Technologies Capital Management first reported a position in TDOC in Q4 2021 and held it in 1 quarter. The position peaked at $230K in Q4 2021. 679 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Gyon Technologies Capital Management reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 2,500 Teladoc Health shares in Q1 2022, an estimated $230K.
  • Gyon Technologies Capital Management first reported a position in Teladoc Health in Q4 2021 and held it in 1 quarter.
  • Gyon Technologies Capital Management's Teladoc Health position peaked at $230K in Q4 2021.
  • 679 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Gyon Technologies Capital Management's 13F filing for Q1 2022, filed 12 May 2022.